Control of B cell development by Ras-mediated activation of Raf

被引:131
|
作者
Iritani, BM
Forbush, KA
Farrar, MA
Perlmutter, RM [1 ]
机构
[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biochem Med Med Genet, Seattle, WA 98195 USA
[3] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[4] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA
[5] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Rahway, NJ 07065 USA
来源
EMBO JOURNAL | 1997年 / 16卷 / 23期
关键词
B cell development; Raf; Ras; transgenic mice;
D O I
10.1093/emboj/16.23.7019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell fate commitment in a variety of lineages requires signals conveyed via p21(ras). To examine the role of p21(ras) in the development of B lymphocytes, we generated transgenic mice expressing a dominant-negative form of Ras in B lymphocyte progenitors, using a novel transcriptional element consisting of the E mu enhancer and the lck proximal promoter. Expression of dominant-negative Ras arrests B cell development at a very early stage, prior to formation of the pre-B cell receptor. Furthermore, an activated form of Raf expressed in the same experimental system could both drive the maturation of normal pro-B cells and rescue development of progenitors expressing dominant-negative Ras. Hence p21(ras) normally regulates early development of B lymphocytes by a mechanism that involves activation of the serine/threonine kinase Raf.
引用
收藏
页码:7019 / 7031
页数:13
相关论文
共 50 条
  • [21] Activation of Raf-1 during experimental gastric ulcer healing is Ras-mediated and protein kinase C-independent
    Pai, R
    Jones, MK
    Tomikawa, M
    Tarnawski, AS
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05): : 1759 - 1766
  • [22] Ras-mediated activation of mTORC2 drives breast cancer cell migration and invasion
    Wiegand, Mollie E.
    Collins, Shannon E.
    Brown, Isabella N.
    Werner, Alyssa N.
    Mundo, Isabelle M.
    Mouneimne, Ghassan
    Charest, Pascale G.
    CANCER RESEARCH, 2022, 82 (12)
  • [23] RAS-mediated radiation resistance is not linked to MAP kinase activation in two bladder carcinoma cell lines
    Gupta, AK
    Bernhard, EJ
    Bakanauskas, VJ
    Wu, JM
    Muschel, RJ
    McKenna, WG
    RADIATION RESEARCH, 2000, 154 (01) : 64 - 72
  • [24] Ras-mediated activation of the TORC2-PKB pathway is critical for chemotaxis
    Cai, Huaqing
    Das, Satarupa
    Kamimura, Yoichiro
    Long, Yu
    Parent, Carole A.
    Devreotes, Peter N.
    JOURNAL OF CELL BIOLOGY, 2010, 190 (02): : 233 - 245
  • [25] Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation
    Kanda, A
    Kawai, H
    Suto, S
    Kitajima, S
    Sato, S
    Takata, T
    Tatsuka, M
    ONCOGENE, 2005, 24 (49) : 7266 - 7272
  • [26] Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation
    Akifumi Kanda
    Hidehiko Kawai
    Shiho Suto
    Shojiro Kitajima
    Sunao Sato
    Takashi Takata
    Masaaki Tatsuka
    Oncogene, 2005, 24 : 7266 - 7272
  • [27] Involvement of B-Raf in Ras-induced Raf-1 activation
    Mizutani, S
    Inouye, K
    Koide, H
    Kaziro, Y
    FEBS LETTERS, 2001, 507 (03) : 295 - 298
  • [28] Ras-mediated suppression of TGFβRII expression in intestinal epithelial cells involves Raf-independent signaling
    Bulus, NM
    Sheng, HM
    Sizemore, N
    Oldham, SM
    Barnett, JV
    Coffey, RJ
    Beauchamp, DR
    Barnard, JA
    NEOPLASIA, 2000, 2 (04): : 357 - 364
  • [29] THERAPEUTIC TARGETS IN RAS-MEDIATED PROLIFERATIVE CMML
    Patnaik, M.
    LEUKEMIA RESEARCH, 2023, 128
  • [30] Ras-Mediated Deregulation of the Circadian Clock in Cancer
    Relogio, Angela
    Thomas, Philippe
    Medina-Perez, Paula
    Reischl, Silke
    Bervoets, Sander
    Gloc, Ewa
    Riemer, Pamela
    Mang-Fatehi, Shila
    Maier, Bert
    Schaefer, Reinhold
    Leser, Ulf
    Herzel, Hanspeter
    Kramer, Achim
    Sers, Christine
    PLOS GENETICS, 2014, 10 (05):